Amaranth Medical, Inc.

New coronary stent technologies were featured among the late-breaking trials and other clinical trial presentations at EuroPCR 2018 in Paris, May 22-25. Here are some of the highlights. BIO-RESORT Sup

Trial data on both established and novel transcatheter valve technologies were among the big device stories coming out of this year's EuroPCR conference in Paris, which also featured new data on biore

To resolve questions raised by a recent series of disappointing clinical trial results, Abbott Laboratories Inc. will soon restrict the availability of its Absorb GT1 BVS bioresorbable drug-elut

Trials of new bioresorbable stents being developed by a number of privately-held companies were featured among the list of trial initiations in the last month, as recorded by Informa's Meddevicetrac